雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy. Kaneko Kaichi 1 , Kawai Shinichi 2 1Department of Internal Medicine, Japanese Red Cross Ashikaga Hospital, Japan./Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Japan. 2Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Japan. pp.1361-1370
Published Date 2014/8/28
DOI https://doi.org/10.20837/4201409083
  • Abstract
  • Look Inside
  • Reference

 Receptor activator of nuclear factor-κB ligand(RANKL)stimulates osteoclast differentiation and activation via binding to its receptor RANK on the pre-osteoclast cells. RANKL is a transmembrane protein, but soluble form(soluble RANKL;sRANKL)is also circulating in the blood. The origins of the sRANKL have been thought to be produced by cleavage of membrane RANKL or secreted by T-lymphocytes, however, it is recently reported that osteocytes were one of the major sources of sRANKL. However, the pathophysiological roles of serum sRANKL has not been clarified yet. We prospectively measured serum sRANKL and OPG levels before and after the initiation of glucocorticoid therapy in patients with systemic autoimmune diseases. It was suggested that serum sRANKL might be a useful marker of bone remodeling in these patients under glucocorticoid therapy. This paper reviewed significance of sRANKL measurement in various bone metabolic diseases including glucocorticoid-induced osteoporosis.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有